Conversion from conventional Sandimmun to Neoral therapy in stable renal transplant recipients.
Løkkegaard
H
H
Department of Nephrology, University Hospital of Herlev, Copenhagen, Denmark.
Asmundsson
P
P
Clausen
P
P
Dieperink
H
H
Hansen
J M
JM
Heaf
J
J
Jensen
S B
SB
Kornerup
H J
HJ
Madsen
S
S
Pedersen
E B
EB
Poulsen
J V
JV
Rasmussen
K
K
D000284:Administration, Oral; D001379:Azathioprine / Q000627:therapeutic use; D001794:Blood Pressure; D003404:Creatinine / Q000097:blood; D016572:Cyclosporine / Q000008:administration & dosage / Q000493:pharmacokinetics* / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005260:Female; D006084:Graft Rejection / Q000453:epidemiology; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000493:pharmacokinetics* / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology* / Q000502:physiology; D008297:Male; D011241:Prednisone / Q000627:therapeutic use; D012044:Regression Analysis
D007166:Immunosuppressive Agents; D016572:Cyclosporine; D003404:Creatinine; D001379:Azathioprine; D011241:Prednisone